Green Thumb Industries (OTC: GTBIF) has expressed interest in merging with Boston Beer (NYSE: SAM), according to a recent report by Pablo Zuanic of Zuanic & Associates. What strategic advantages does this merger offer?
Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology,